BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Helmholtz Zentrum Muenchen GmbH

Headquarters: Neuherberg, Germany
Year Founded: 1960
Status: Non-biopharma

Biopharma related deals can be found by searching the organization's name in the Deals Module.

BioCentury | Feb 27, 2025
Distillery Therapeutics

Inhibiting cathepsin B for pulmonary fibrosis

BioCentury | Mar 26, 2024
Distillery Therapeutics

Inhibiting inceptor for hyperglycemia in obesity

BioCentury | Feb 23, 2022
Deals

BioNTech adds to TCR arsenal with Medigene’s PRAME, platforms

The deal includes a switch technology that converts immunosuppressive ligands into costimulatory signals
BioCentury | Feb 11, 2022
Distillery Therapeutics

Phenotype-guided identification of small molecules for fibrosis

BioCentury | Dec 3, 2021
Discovery & Translation

Mapping the plasma proteome to identify drug targets; plus GSK-Vir, Codiak and more

BioCentury’s roundup of translational news
BioCentury | Dec 11, 2019
Emerging Company Profile

Flagship’s Cellarity maps out network-based drug discovery

Flagship launches Cellarity to deploy single cell technologies to find compounds that hit whole networks
BioCentury | Dec 11, 2019
Politics & Policy

Travel ban blocks team from receiving ASH accolades

BioCentury | Apr 30, 2019
Distillery Therapeutics

GP1BB identified as NASH target

BioCentury | Jan 23, 2018
Distillery Therapeutics

Endocrine / Metabolic

Items per page:
1 - 10 of 20
Help Center
Username
Request Training
Submit Data Correction
Ask a Question